Search results for ESCCongress
ESCCongress community
One keyword maps to one global community path.
People
Not Found
Tweets including ESCCongress
Help shape the discussion at #ESCCongress# 2026 by sharing your experience of managing patients with heart failure and kidney impairment.
Which unmet need in HF with kidney impairment management are you most hopeful new evidence will address?
Show more
Help shape the discussion at #ESCCongress# 2026 by sharing your experience of managing patients with heart failure and kidney impairment.
A patient's eGFR dips after starting an SGLT2 inhibitor. What's your first move?
Show more
Help shape the discussion at #ESCCongress# 2026 by sharing your experience of managing patients with heart failure and kidney impairment.
What's the biggest barrier to optimising HF GDMT in patients with kidney impairment?
Show more
Help shape the discussion at #ESCCongress# 2026 by sharing your experience of managing patients with heart failure and kidney impairment.
Which kidney biomarker most influences your heart failure management decisions?
Show more
Help shape the discussion at #ESCCongress# 2026 by sharing your experience of managing patients with heart failure and kidney impairment.
How often do you test UACR (urine albumin-to-creatinine ratio) in patients with HF?
Show more
Obesity and cardiovascular inflammation remain urgent challenges. At ESC Congress 2026, we're spotlighting science that drives innovation - and lasting health.
The global POSEIDON study assembles real‑world evidence from 18,000+ patients across 18 countries. Findings put the global burden of CV inflammation in HF on record.1 Learn more at ESC Congress 2026, Hall A2 Stand
T100.
Show more
Breaking from #EASLCongress#: Observational data show IBAT inhibitor promise for pruritus in late-onset PFIC and ICP.
Read the full story:
Live from #EASLCongress#: Intrahepatic cholestasis of pregnancy recurs in 4 in 10 pregnancies.
Get the full story:
Looking for an expert overview of highlights from #EASLCongress#?
In this short video, Dr Silvia Vilarinho and Dr Deepak Joshi discuss key takeaways in late-onset genetic cholestasis and Alagille syndrome.
Start watching now:
Show more
